Page last updated: 2024-10-28

ha14-1 and Sensitivity and Specificity

ha14-1 has been researched along with Sensitivity and Specificity in 2 studies

ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate: a BH3 mimetic; synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia

Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hetschko, H1
Voss, V1
Senft, C1
Seifert, V1
Prehn, JH1
Kögel, D1
Lickliter, JD1
Cox, J1
McCarron, J1
Martinez, NR1
Schmidt, CW1
Lin, H1
Nieda, M1
Nicol, AJ1

Other Studies

2 other studies available for ha14-1 and Sensitivity and Specificity

ArticleYear
BH3 mimetics reactivate autophagic cell death in anoxia-resistant malignant glioma cells.
    Neoplasia (New York, N.Y.), 2008, Volume: 10, Issue:8

    Topics: bcl-2-Associated X Protein; bcl-X Protein; Benzamides; Benzopyrans; Biomimetic Materials; Caspases;

2008
Small-molecule Bcl-2 inhibitors sensitise tumour cells to immune-mediated destruction.
    British journal of cancer, 2007, Feb-26, Volume: 96, Issue:4

    Topics: Adult; Antineoplastic Agents; Benzopyrans; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation;

2007